[Recalled] Prismaflex Control Unit, software versions below 7.21 — Communication error alarms may result in interruption of therapy, delay in ther… | FDA 2019-10-04
The product on this page is subject to an official recall. We summarise the regulator's findings and the recommended action.
Recall details
| Product | Prismaflex Control Unit, software versions below 7.21 |
|---|---|
| Brand / manufacturer | Baxter Healthcare Corporation |
| Category | device |
| Issuing authority | FDA_DEVICE |
| Reference | Z-0280-2020 |
| Country of notice | United States |
| Risk level | Class II |
| Hazard type | recall |
| Notice date | 04 October 2019 |
| EAN / barcode | 6023014700 |
Why it was recalled
According to the FDA_DEVICE notice, the identified hazard is: Communication error alarms may result in interruption of therapy, delay in therapy, or blood loss due to non-restitution of blood in the extracorporeal circuit.
This Class II recall concerns device products distributed in United States and was recorded by FDA_DEVICE. Recalls in this category are published so that owners, retailers, and importers can identify affected units and act quickly.
What to do if you own this product
Check whether your unit is affected and follow the authority's guidance before further use.
Read the full official notice →
Related recalls from Baxter Healthcare Corporation
This page indexes a public government recall notice for reference. We do not sell or verify this product; always confirm the current status on the authority's official site.